Frequency of BCR-ABL Transcript Types in Syrian CML Patients

Background. In Syria, CML patients are started on tyrosine kinase inhibitors (TKIs) and monitored until complete molecular response is achieved. BCR-ABL mRNA transcript type is not routinely identified, contrary to the recommendations. In this study we aimed to identify the frequency of different BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhat-Maghribi, Sulaf, Habbal, Wafa, Monem, Fawza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904091/
https://www.ncbi.nlm.nih.gov/pubmed/27313614
http://dx.doi.org/10.1155/2016/8420853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904091/
https://www.ncbi.nlm.nih.gov/pubmed/27313614
http://dx.doi.org/10.1155/2016/8420853

Ejemplares similares